Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
4. Severe infections are treated with ganciclovir and CMV Ig. AIDS patients may
develop resistance to ganciclovir, so foscarnet and cidofovir are second line therapies.
6. A Monospot test can be run to look for heterophile antibodies; however, these are
only produced about one-half the time in EBV patients. Blood smear should show at
least 50% swollen lymphocytes with lobulated nuclei in EBV; CMV causes a high
percentage of swollen lymphocytes. A shell vial assay can be run to demonstrate
CMV infection. More modern techniques include PCR analysis.
7. The first IgG expression is directed to VCA (viral capsid antigen), likely due to the
high level expression of this antigen. Later, IgG to EBNA (Epstein-Barr nuclear
antigens) proteins is raised, even though these antigens are expressed before VCA. A
patient that is VCA+ EBNA- is likely undergoing an acute, primary infection whereas
a patient that is VCA+ EBNA+ likely had a past infection.
9. KSHV (HHV-8) has been found in more than 90% of KS tumors, both AIDS-related
and classical KS, but is almost never found in the general population of the US. It is
not sufficient to cause KS alone because it must rely on a drop in the immune
response to lead to KS.
10. AIDS-related KS: Sexually transmitted, but apparently absent from semen. Almost
exclusively seen in gay men, virtually never seen in lesbians or patients who
contracted AIDS via blood transfusion. HIV infection provides the necessary
immunosuppression. Once, half of all AIDS patients developed KS within 10 years
of AIDS diagnosis, now significantly reduced and well controlled. Treatment targets
HIV, not KSHV.